InSpan granted patent protection by the US Patent Office for its unique interspinous technique and instruments designed for treating spinal stenosis and fusion in the ASC
MALDEN, Mass., March 21, 2023 /PRNewswire-PRWeb/ -- NANISX LLC is the parent company for InSpan LLC and is grateful that the US Patent Office (USPTO) has allowed for issuance as a patent to protect the unique InSpan approach. This is yet another momentous achievement and a leap forward for patients with spine pain, especially over 55 years old, who want a safe and less invasive surgery with quick recovery in an outpatient ambulatory surgery center (ASC).
- On March 8th, 2023, the US Patent Office allowed for issuance as a patent of the InSpan technique and unique instruments establishes InSpan as a proven and validated leading technology for interspinous-interlaminar fixation ideally suited for outpatient spine surgery to treat spinal stenosis and for spinal fusion.
- MALDEN, Mass., March 21, 2023 /PRNewswire-PRWeb/ -- NANISX LLC is the parent company for InSpan LLC and is grateful that the US Patent Office (USPTO) has allowed for issuance as a patent to protect the unique InSpan approach.
- InSpan has been FDA-cleared since 2010 and thousands have been implanted safely with excellent clinical outcomes and no adverse device related events.
- Visit InSpan to request help in locating a doctor near you that performs InSpan surgeries.